ロード中...
Clinical utility of valsartan in the treatment of hypertension in children and adolescents
Valsartan is a potent antagonist of the type 1 angiotensin receptor (AT(1)). By blocking the actions of angiotensin II on the AT(1), it inhibits vasoconstriction and synthesis of aldosterone thus lowering systemic blood pressure. Valsartan has been approved by the FDA for the treatment of hypertensi...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3090375/ https://ncbi.nlm.nih.gov/pubmed/21573045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S12166 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|